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Stent Migration: A Risk in the Treatment of Renal
Access Patients
Andrew J. Olinde1, Devin Conway1, Jay Hollman1, John
Schellack2, Paul Perkowski2, Joseph Grifﬁn1. 1Vascular
Specialty Center, Baton Rouge, La; 2Vascular Clinic,
Baton Rouge, La
Objectives: Central venous strictures often lead to
signiﬁcant arm swelling and access malformation in patients
with chronic renal failure. The purpose of this study is to
acknowledge the risk of stent migration in this subset of
patients treated for failing access grafts.
Methods: A retrospective chart review of patients
undergoing diagnostic ﬁstulagrams and percutanous inter-
vention of malfunctioning accesses was done from June
2007 to November 2012 in two major hospitals in Baton
Rouge, Louisiana. A total of 5184 ﬁstulagrams were per-
formed. 1189 (22.9%) procedures involved percutaneous
thrombectomy of the accesses. 2882 (55.6%) procedures
included balloon dilatation of the access or venous outﬂow
strictures. 796 (15.3%) patients had stents placed either in
the access or proximal central veins.
Results: Of the 796 stents placed in this series, six
migrated after deployment over varied time periods. Five
stents migrated to the heart requiring open heart surgical
removal. One patient had a stent migrate from the right
subclavian vein to the innominate vein.
Conclusions: Migration of stents can occur in the treat-
ment of failing renal access grafts. This is the largest reported
series to date in the literature of such events in renal failure
patients. The majority of stents migrated to the heart. The
high ﬂow system generated by these renal access grafts and
eventual gradual central vein dilatation in this patient popula-
tion increase the risk of future migration. Interventionalists
must be cognizant of this potential complication with the
need for selective accurate placement of stents.Despite proper
placement, stent migration may be unavoidable.
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Patients 1 2 3 4 5
BM-bare metal
CS-covered
10 mm  26 mm BM 7 mm  40 mm CS 9 mm  40 mm BM 10 mm  60 mm
BM 12 mm  60 mm BM
11 mm  100 mm
CS
Location placed Subclavian vein Proximal access graft Basilic vein Common and external
iliac veins
Subclavian vein
Migration
diagnosed
4 days Same day 3 years 6 weeks 8 months
Migration destiniation Tricuspid valve Pulmonary valve Tricuspid valve Right atrium and right ventricle Innominate vein
Treatment Open heart retrieval Open heart retrieval Postmortem retrieval Open heart retrieval Balloon dilatation
of stentPS82.
Race and Insurance Status Have Limited Effect on
Long-Term Vascular Access Outcomes in Patients at
an Inner City University Hospital
Jeffrey J. Siracuse, Adi Wollstein, Yuriy Kotsurovskyy,
Diana Catz, Irene Epelboym, In-Kyong Kim, Heather
L. Gill, Nicholas J. Morrissey. New York-Presbyterian
Hospital, Columbia University, College of Physicians
and Surgeons, New York, NY
Objectives: Insurance status and race are potential
barriers to health care maintenance. We assessed their
contribution to upper extremity vascular access outcomes
in our population.
Methods: We retrospectively reviewed outcomes of
601 vascular access patients from 2004-2012 at our institu-
tion. We recorded patient demographics, comorbidities,
and complications. Primary outcomes were reintervention,
long-term mortality, and kidney transplantation.
Results: Arteriovenous ﬁstulas (AVF) accounted for
majority (66%) of operations. Median age was 62, 58%
were male. Race, a self-reported variable, was 50%Hispanic,
22% white, and 19% black. Most had Medicare only (42%),
while 31% had private insurance and 27% had Medicaid.
Black patients were less likely to get an AVF compared to
whites and Hispanics (P < .05). White patients were signif-
icantly older than either Hispanics or blacks (68 vs 61 vs 58;
P< .05). Overall freedom from reintervention at 5 years was
55%, with infection (HR, 2.0; 95% CI, 1.3-3.0), stenosis
(HR, 3.2; 95% CI, 2.3-4.3), thrombosis (HR, 1.7; 95%
CI, 1.2-2.4), and nerve injury (HR, 4.1; 95% CI, 1.5-
11.5) being independent predictors of reintervention.
Mortality at 5 years was 35%, predicted by AV graft place-
ment (HR, 1.9; 95% CI, 1.4-2.7), low albumin (HR, 0.7;
95% CI, 0.6-0.9), white race (HR, 1.9; 95% CI, 1.3-2.8),
and not receiving a kidney transplant (HR, 0.3; 95% CI,
0.2-0.6). Transplantation rate was 31% at 5 years and pre-
dicted by high albumin (HR, 1.9; 95% CI, 1.4-2.6), AVF
(HR, 1.6; 95%, 1.1-2.6), and no CAD (HR, 0.6; 95% CI,
0.4-0.9). Race and insurance status did not affect reinterven-
tion or transplantation rate.
Conclusions: Controlling for patient and clinical
factors, insurance status did not have a signiﬁcant effect
on long term vascular access outcomes in our population.
Race was not signiﬁcantly associated with reintervention
or transplantation, however more black patients had less
suitable vasculature for AVF, and white patients had a lower
long term survival, possibly due to more advanced age.
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Fistula First, Graft on Arterialized Vein Second
Giuseppe Galzerano1, Michele Giubbolini1, Francesco
Setacci1, Gianmarco de Donato1, Pasqualino Sirignano1,
Alessandro Cappelli1, Gabriele Messina2, Carlo Setacci1.
1Department of Medicine, Surgery and Neuroscience,
Vascular and Endovascular Surgery Unit, University of
Siena, Siena, Italy; 2Department of Molecular and
Developmental Medicine, University of Siena, Siena, Italy
Objectives: Arterovenous grafts (AVG)present a fea-
sible solution for creating a conduit in patients with end stage
renal failure who are unsuitable for autogenous ﬁstula
(AVF). Unfortunately, these vascular conduits are fraught
with complications and failing access remains the leading
cause of hospitalization for patients undergoing dialysis.
The aim of this study is to assess the prevention rate of
vein stenosis, placing a graft on an arterialized vein (GAV)
instead of an anastomized AVG in a native vein (GNV).
Methods: This was a cohort study conducted from
January 2009 to November 2012. All consecutive patients
who underwent AVG in our institution were included. All
patients requiring a secondary intervention were also
referred to our center. Last follow-up data were recorded
by telephonic interviews with the hemodyalisis units
that had referred patients to our department. Graft
closures caused by pseudoaneurysm, death, infections,
transplants, or related to proximal anastomosis were
excluded from the data analysis. A Kaplan-Meier method
was used to plot GAV-patency and GNV-patency; a Log-
rank test was used to identify whether signiﬁcant differ-
ence (P < .05) existed between GAV and GNV.
Results: During the study 46 grafts were placed (299
access-related procedures). Twenty patients had arterial-
ized receiving veins (group A), while 26 patients received
an AVG immediately because they lacked autogenous
veins suitable for ﬁstula (group B). The average follow-
up period was 16,1 months (range, 0-41). The group A
41 months-patency rate was 84.3%, while group B was
43.7% (P ¼ .06). Secondary patency was similar in the
two groups.
Conclusions: Vein Arterialization seems to prevent
venous stenosis improving AVG-patency rate. This ﬁnding
increases the signiﬁcance of ﬁstula ﬁrst approach even if
a transposition or elevation is required, due to the positive
results of placing grafts on arterialized vein for failed
ﬁstulas. More data are needed to improve statistical value;
however, the borderline P-value encourages new studies.
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Median Arcuate Ligament Syndrome: Evolution of
Management at a Regional Institution
Neelima Katragunta, Nicholas Drahush, Larry R. Sprouse.
University of Tennessee, Chattanooga, Tenn
Objectives: Median Arcuate Ligament Syndrome
(MALS) remains one of the most controversial disease enti-
ties in vascular surgery. Its rarity and doubts about its mere
existence often lead to a delay in diagnosis and/or subop-
timal management of the disease. As a regional center, we
present our experience in selecting and managing these
patients.
Methods: A retrospective analysis of 27 patients that
underwent surgical intervention for MALS between Jan
2006 to June 2012 was conducted to characterize patient
demographics, presenting symptoms, method of selection
and management, and symptomatic relief.
Results: The average age of the patient population was
54.8 years (range 18 to 76 years) and they were predomi-
nantly female (81%, 22 patients). Postprandial abdominal
pain was the main symptom (93%), followed by nausea
(85%), weight loss (85%), and diarrhea (37%). An inspira-
tory/expiratory arteriogram was performed in 26 (96%)
patients prior to surgery in order to conﬁrm the diagnosis.
All patients underwent open division of median arcuate liga-
ment and an additional revascularization procedure (celiac
artery patch angioplasty in 15, arterial bypass in 11 and
endarterectomy in one patient). Symptomatic relief was
seen in 23 (85%) of patients at 6 month follow-up. Late
recurrence of symptoms was seen in ﬁve (18.5%) patients.
Of the ﬁve (18.5%) patients that required reintervention,
only one required an open surgical repair. Complications
were seen in four (14.8%) patients (wound infection, hernia,
pancreatitis, and venous thromboembolism).
Conclusions: With careful patient selection and
appropriate management, MALS can be managed with
satisfactory outcomes. In our experience, open surgical
release of the median arcuate ligament, along with arterial
reconstruction is key to restoring adequate ﬂow and for
symptomatic relief. As our experience has evolved over
years, arterial bypass has become our preferred method of
arterial reconstruction.
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Early and Mid-Term Results of Endovascular Treatment
of Visceral Artery Aneurysms
Walter Dorigo, Raffaele Pulli, Irene Spina, Leonidas Azas,
Aaron Fargion, Alessandro Alessi Innocenti, Carlo Pratesi.
Vascular Surgery, University of Florence, Florence, Italy
Objectives: To retrospectively analyze early and
follow-up results of endovascular management of visceral
artery aneurysms in a single centre experience.
Methods: From January 2007 to December 2012, 21
consecutive endovascular interventions for visceral artery
aneurysms were performed in 21 patients; pre, intra and
postoperative data were prospectively collected in a
